Back to Journals » OncoTargets and Therapy » Volume 15

Rapid and Efficient Response to Gilteritinib and Venetoclax-Based Therapy in Two AML Patients with FLT3-ITD Mutation Unresponsive to Venetoclax Plus Azacitidine

Total article views   HTML views PDF downloads Totals
8,183 Dovepress* 7,197+ 419 7,616
PubMed Central* 986 324 1,310
Totals 8,183 743 8,926
*Since 18 February 2022
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 2 4

View citations on PubMed and Google Scholar